APA (7th ed.) Citation

I, B., & ZY, K. (2026). Reclassification of NSAID hypersensitivity according to the WAO 2025 guidelines: Insights from a cohort of 527 patients. Allergologia et immunopathologia, 54(1), 166. https://doi.org/10.15586/aei.v54i1.1579

Chicago Style (17th ed.) Citation

I, Bulut, and Katran ZY. "Reclassification of NSAID Hypersensitivity According to the WAO 2025 Guidelines: Insights from a Cohort of 527 Patients." Allergologia Et Immunopathologia 54, no. 1 (2026): 166. https://doi.org/10.15586/aei.v54i1.1579.

MLA (9th ed.) Citation

I, Bulut, and Katran ZY. "Reclassification of NSAID Hypersensitivity According to the WAO 2025 Guidelines: Insights from a Cohort of 527 Patients." Allergologia Et Immunopathologia, vol. 54, no. 1, 2026, p. 166, https://doi.org/10.15586/aei.v54i1.1579.